Evidence map›Paper›PMID 36012368›Full record

ArticleInternational journal of molecular sciences2022

NOS1AP Interacts with α-Synuclein and Aggregates in Yeast and Mammalian Cells.

Anton B Matiiv, Svetlana E Moskalenko, Olga S Sergeeva, Galina A Zhouravleva, Stanislav A Bondarev

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Sigma-1 Receptor Activation by Fluvoxamine Ameliorates ER Stress, Synaptic Dysfunction and Behavioral Deficits in a Ketamine Model of Schizophrenia.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  3. Dizocilpine Does Not AlterInternational journal of molecular sciences · 2025
    Article
  4. Special Issue "Neurobiology of Protein Synuclein".International journal of molecular sciences · 2024
    Article
  5. Biomedicines · 2024
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anton B MatiivDepartment of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia.ORCID 0000-0002-0222-2374
Svetlana E MoskalenkoDepartment of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia.ORCID 0000-0003-0419-0000
Olga S SergeevaDepartment of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia.
Galina A ZhouravlevaDepartment of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia.ORCID 0000-0002-3013-4662
Stanislav A BondarevDepartment of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia.ORCID 0000-0003-3137-944X
St Petersburg University · RU

Funding

Russian Foundation for Basic Research 20-34-90117
6 · The paper itself

Abstract

The

Indexed as

Adaptor Proteins, Signal Transducingalpha-SynucleinSaccharomyces cerevisiaeAnimalsNeuronsNitric Oxide Synthase Type IRatsSignal TransductionSynucleinopathiesAdaptor Proteins, Signal Transducingalpha-SynucleinNitric Oxide Synthase Type INOS1AP protein, ratNos1 protein, ratCAPONNOS1APprotein aggregationschizophreniasynucleinopathiesα-synuclein

Identifiers

PMID36012368
PMCPMC9409085
OpenAlexW4291465476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.